Klaudius Siegfried
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
- Treatment of Major Depression
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 6
- Treatment of Major Depression 3
-
- Dementia and Cognitive Impairment Research 4
- Co-authors
- Gordon Wilcock (1 shared paper)Romola S. Bucks (1 shared paper)James C. Patterson (1 shared paper)Neal R. Cutler (1 shared paper)Stephen Curran (1 shared paper)D. Wyper (1 shared paper)Klaus P. Ebmeier (1 shared paper)Catherine Murray (1 shared paper)
- Journals
- European Neuropsychopharmacology (3 papers)Human Psychopharmacology Clinical and Experimental (2 papers)Annals of the New York Academy of Sciences (1 paper)Age and Ageing (1 paper)The Journal of Prevention of Alzheimer s Disease (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
Klaudius Siegfried
14 papers receiving 594 citations
Peers
Comparison fields: 5 of 81
- Psychiatry and Mental health 242
- Pharmacology 135
- Geriatrics and Gerontology 23
- Neurology 40
- Cognitive Neuroscience 90
Countries citing papers authored by Klaudius Siegfried
This map shows the geographic impact of Klaudius Siegfried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaudius Siegfried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaudius Siegfried more than expected).
Fields of papers citing papers by Klaudius Siegfried
This network shows the impact of papers produced by Klaudius Siegfried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaudius Siegfried. The network helps show where Klaudius Siegfried may publish in the future.
Co-authors
The 14 scholars most cited alongside Klaudius Siegfried, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 421 | |
| 2 | 1992 | 54 | |
| 3 | 1993 | 33 | |
| 4 | 1986 | 29 | |
| 5 | Nomifensine in geriatric inpatients: a placebo-controlled study. | 1984 | 17 |
| 6 | 1984 | 16 | |
| 7 | Alzheimer's disease : clinical and treatment perspectives | 1995 | 15 |
| 8 | 1985 | 13 | |
| 9 | 1991 | 9 | |
| 10 | 1995 | 7 | |
| 11 | Pharmacodynamics of nomifensine: a review of studies in healthy subjects. | 1984 | 4 |
| 12 | 1989 | 3 | |
| 13 | 2015 | 1 | |
| 14 | 1994 | 1 | |
| 15 | 1991 | 1 |
About Klaudius Siegfried
Klaudius Siegfried is a scholar working on Pharmacology, Psychiatry and Mental health, Cognitive Neuroscience, Experimental and Cognitive Psychology and Cellular and Molecular Neuroscience, having authored 15 papers that have together received 624 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (6 papers), Dementia and Cognitive Impairment Research (4 papers), Treatment of Major Depression (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Functional Brain Connectivity Studies (2 papers) and Neurological Disorders and Treatments (2 papers). The work is most often cited by research in Psychiatry and Mental health (242 citations), Pharmacology (135 citations), Geriatrics and Gerontology (23 citations), Neurology (40 citations) and Cognitive Neuroscience (90 citations). Klaudius Siegfried has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Gordon Wilcock, Romola S. Bucks, James C. Patterson, Neal R. Cutler, Stephen Curran, D. Wyper, Klaus P. Ebmeier, Catherine Murray, Robert Hunter and Guy M. Goodwin. Their work appears in journals such as European Neuropsychopharmacology, Human Psychopharmacology Clinical and Experimental, Annals of the New York Academy of Sciences, Age and Ageing and The Journal of Prevention of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.